Literature DB >> 11720323

Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.

F Martínez1, P Nos, S Benlloch, J Ponce.   

Abstract

Cutaneous manifestations occur frequently in inflammatory bowel disease. The association between hidradenitis suppurativa (HS) and Crohn's disease (CD) has been reported. We present a new case supporting this association. A dramatic improvement after treatment with infliximab was achieved for both refractory fistulizing CD and axillary HS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720323     DOI: 10.1097/00054725-200111000-00008

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  19 in total

1.  Comorbidities of hidradenitis suppurativa (acne inversa).

Authors:  Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2010-01

2.  Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.

Authors:  H Batoulis; M S Recks; F O Holland; F Thomalla; R O Williams; S Kuerten
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

Review 3.  Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.

Authors:  Mariabeatrice Principi; Nicoletta Cassano; Antonella Contaldo; Andrea Iannone; Giuseppe Losurdo; Michele Barone; Mario Mastrolonardo; Gino Antonio Vena; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 4.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

5.  Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab.

Authors:  Ian Gorovoy; Adar Berghoff; Laura Ferris
Journal:  Case Rep Dermatol       Date:  2009-10-27

Review 6.  Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.

Authors:  S L Johnston
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

7.  Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.

Authors:  Natalie Z Sun; Teresa Ro; Puneet Jolly; Christopher J Sayed
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

8.  Outcomes After Combined Radical Resection and Targeted Biologic Therapy for the Management of Recalcitrant Hidradenitis Suppurativa.

Authors:  Michael V DeFazio; James M Economides; Kathryn S King; Kevin D Han; Victoria K Shanmugam; Christopher E Attinger; Karen K Evans
Journal:  Ann Plast Surg       Date:  2016-08       Impact factor: 1.539

9.  Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario.

Authors:  Francesco Giudici; Laura Maggi; Raffaella Santi; Lorenzo Cosmi; Francesco Annunziato; Gabriella Nesi; Giusi Barra; Gabrio Bassotti; Raffaele De Palma; Francesco Tonelli
Journal:  Clin Mol Allergy       Date:  2015-07-22

Review 10.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.